Proton-pump inhibitor recalled

One lot of pantoprazole sodium for injection (40 mg per vial) was recalled in December.


One lot of pantoprazole sodium for injection (40 mg per vial) was recalled from hospitals nationwide, the FDA announced on Dec. 20, 2017.

The proton-pump inhibitor, given by IV infusion, is indicated for the short-term treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis and pathological hypersecretion, including Zollinger-Ellison syndrome.

Manufacturer AuroMedics Pharma initiated the recall after a report that one vial from the 10-vial batch contained a piece of glass. Recalled products were shipped in August 2017.